Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-15 · accession 0001309653-22-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-16 | 2022-09-15 | LSTA | AZAB MOHAMMAD | Dir | A - Grant | $6.25 | +19.2K | 19.2K | New | +$120.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-15 | A | A | 19,200 | $6.25 | 19,200 | D | — | — | (F1) Represents 19,200 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock units will vest in equal annual installments over a three-year period with the initial vesting on September 15, 2023. |